Diana Barb

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui et al. · Hepatology · 2023 · 2.3K citations · Full text

Medicine, Pediatrics, Hepatology +13

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril et al. · Diabetes Care · 2020 · 347 citations · Full text

Medicine, Internal Medicine, Pathology +17

Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease

Fernando Bril, Diana Barb, Paola Portillo-Sánchez et al. · Hepatology · 2016 · 290 citations

Medicine, Endocrinology, Internal Medicine +17

Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes

Kenneth Cusi, Fernando Bril, Diana Barb et al. · Diabetes Obesity and Metabolism · 2018 · 197 citations

Medicine, Endocrinology, Pharmacology +17

Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease

Diana Barb, Enrico Repetto, Michael Edward Stokes et al. · Obesity · 2021 · 144 citations · Full text

Medicine, Internal Medicine, Pathology +16